1. Home
  2. EKSO vs CPHI Comparison

EKSO vs CPHI Comparison

Compare EKSO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$5.51

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.27

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EKSO
CPHI
Founded
2005
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EKSO
CPHI
Price
$5.51
$1.27
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
326.9K
53.6K
Earning Date
10-28-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,749,000.00
$4,052,266.00
Revenue This Year
N/A
N/A
Revenue Next Year
$54.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.73
$1.18
52 Week High
$14.97
$3.35

Technical Indicators

Market Signals
Indicator
EKSO
CPHI
Relative Strength Index (RSI) 65.38 31.94
Support Level $4.56 $1.18
Resistance Level $5.09 $1.49
Average True Range (ATR) 0.31 0.12
MACD 0.11 -0.03
Stochastic Oscillator 92.68 12.57

Price Performance

Historical Comparison
EKSO
CPHI

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: